Haplogen
Haplogen is a young biopharmaceutical company with the mission to improve human health by combating infectious disease.
| Date | Investors | Amount | Round |
|---|---|---|---|
£6.0m | Acquisition | ||
€70.0k | Grant | ||
| Total Funding | $77.0k | ||
| Date | Investors | Amount | Round |
|---|---|---|---|
£6.0m | Acquisition | ||
€70.0k | Grant | ||
| Total Funding | $77.0k | ||